Use of Dexamethasone via Two Methods in PENG Block for Patients Undergoing Femoral Fracture Surgery: A Prospective Observational Study

两种方法在股骨骨折手术患者中应用地塞米松进行PENG阻滞:一项前瞻性观察研究

阅读:1

Abstract

Objectives: This study investigates the effectiveness of dexamethasone when utilized as an adjunct agent in enhancing the outcomes of a pericapsular nerve group (PENG) block compared to its systemic administration for managing pain in patients having surgery for femoral fractures. Methods: This study enrolled 44 patients who received a PENG block following spinal anesthesia. Two groups were formed by stratifying the patients, involving those in whom dexamethasone was received through perineural administration (Group P, n = 22) and those in whom it was received through systemic administration (Group S, n = 22). Information concerning the demographic features of the patients, along with operative and postoperative details, was meticulously documented for analysis. The patients' pain levels were recorded using the numerical rating scale (NRS) at multiple time points. Results: In the perineural dexamethasone group, the length of time of sensory and motor blockade and the time elapsed until the initial analgesic requirement were longer (p < 0.001). The consumption of tramadol and the pain scores measured were noted to be decreased. (p < 0.001). There were no notable distinctions regarding patient mobilization or the length of inpatient stay. Conclusions: The perineural administration of dexamethasone in PENG block procedures may provide more effective analgesia for surgeries involving femoral neck fractures. By minimizing the use of systemic opioids, it may also help mitigate potential side effects. These findings indicate that perineural dexamethasone could serve as a beneficial adjuvant agent for patients undergoing femoral neck fracture surgeries.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。